Sandra Perreand, MBA


Lifting the Medical and Economic Burden of AMR in the US

This bipartisan initiative highlights the need for a comprehensive approach to combat antimicrobial resistance (AMR), incorporating both antibiotic drug development and increased funding for stewardship programs.

Elysia Burke, PharmD


Febrile Finesse: Are We Employing Appropriate Empiric Coverage in Patients With Neutropenic Fever?

Traditional therapy coverage does not include recent data that offers some updates in evaluating the current effectiveness of empiric antibiotic treatment.

Audry Hawkins, PharmD


SHARE the Responsibility of Antibiotic Stewardship With Our Patients

How pharmacists can use shared decision-making to improve antibiotic use.

Andrew Skinner, MD


Key Takeaways on FMTs in the Treatment of CDI

Experts provide practice pearls for educating patients on and using FMTs for the management of CDI.

Alexandra L. Cunha, PharmD


The Next Generation of COVID-19 Vaccines and Boosters

Will there be an answer to keep the continuously evolving virus at bay? Are seasonal combination vaccines the wave of the future?

Caroline Teter, PA-C


Lessons in Resilience: What HIV Teaches Us About COVID-19

Four lessons learned from the AIDS crisis that can be applied to the fight against our current pandemic.

Meredith Oliver PharmD, BCIDP


Expanded Treatment Options for Multi-Drug Resistant Infections in Children

In the latest article from SIDP, here is a look at therapy options addressing this emerging clinical challenge.

Jason Chao, PharmD; and Nicola Clayton, PharmD, BCID


How Do You Measure the Success of Your Stewardship Program?

The challenging search for a metric that effectively evaluates an ASP’s direct impact on appropriate antimicrobial use and improved patient outcomes.

Uzma Syed, DO, FIDSA


Respiratory Virus Season: Colds and COVID-19 Update

Will this winter bring the feared twindemic of SARS-CoV-2 and influenza, or will another common infection reemerge?

Kelly R. Reveles, PharmD, PhD, BCPS


Looking Toward the Future of CDI Management

Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.

Ngofeen Mputubwele


A Viral Colonial Legacy: HIV, Monkeypox Emerged Due to Ongoing Colonial Viral Neglect

Similar to HIV, the colonial and postcolonial history is fundamental to the biology of this monkeypox outbreak.

Deanna J. Buehrle, PharmD


Bacterial Coinfections Among US Patients With Coronavirus Disease 2019

Implications for antimicrobial use and antimicrobial resistance.

Kevin Nguyen, PharmD


Discussing Outpatient COVID-19 Treatments

Here is a look at some of the treatment alternatives, which can offer simpler logistics and cost considerations.

Robbie Lee Anne Christian, Pharm.D., BCIDP, AAHIVP


Examining RSV Vaccines for Seniors

Two RSV vaccines for seniors were FDA approved this year and here is an overview of the vaccines and the study data.

Catherine DeVoe, MD, and Peter Chin-Hong, MD


Varicella Zoster Virus and Human Papillomavirus Vaccination in Immunocompromised Patients

Vaccination for VZV and HPV requires special consideration in immunocompromised patients. They are at risk for more severe viral illnesses if not immune, but they may also have decreased response to, and increased adverse effects from, vaccines.

Karen Tan, PharmD, BCIDP


Cefiderocol’s Role in Managing Carbapenem-Resistant Acinetobacter baumannii Infections

This agent is likely best utilized as part of a combination when treating this bacterium but data regarding appropriate combinations are scarce.

Richelle L. Guerrero-Wooley, MD


COVID-19 Impact on Antimicrobial Stewardship: Consequences and Silver Linings

This crisis has united multidisciplinary groups and laid the foundation to better equip the health care workforce for future pandemics.

Rajeev Shah, PharmD, AAHIVP, BCIDP


Ready, Set, Cabenuva: Implementing Cabotegravir/Rilpivirine

This novel therapeutic option represents the first long-acting injectable approved for maintenance of HIV-1 suppression.

Bo Ram Keum, PharmD candidate


Safety of Cefazolin Has Been Underestimated for GBS Prophylaxis During Labor

Both undertreatment and overtreatment were common in this cohort of penicillin-allergic pregnant women with Group B Streptococcus (GBS).

Renata O. Smith, PharmD, AAHIVP


Gender-Affirming Care in Persons Living With HIV

Gender-affirming hormone therapy (GAHT) therapy consists of administration of exogenous hormones and suppression of endogenous hormone production, with the goal of obtaining characteristics more congruent with an individual’s gender identity. Here is a review of these therapies and consideration for PrEP and the risks associated with HIV in this diverse population.

Kari A. Mergenhagen, PHARMD, BCPS, BCIDP


Outpatient Antimicrobial Stewardship: The Keys to Developing a Successful Program

This form of stewardship can reduce unnecessary antibiotic prescribing, reduce costs, and optimize patient outcomes.

Shane J. Softy


Pharmacotherapy Options for COVID-19: Does Fluvoxamine Have a Place in Therapy?

The need for safe and effective treatment against the various strains of COVID-19 increase, and investigators continue to assess various pharmacologic options.

Tori Whitacre Martonicz


Leishmaniasis: No Longer Just a Tropical Disease—Now Endemic in the US

A senior microbiologist gives audiences of sister brands, Infection Control Today and Contagion, an insight into leishmaniasis, a potentially fatal disease.

Jonathan H. Ryder, MD


Updates and Controversies in Necrotizing Soft Tissue Infections

Changes in microbiology and antimicrobial resistance patterns warrant reevaluation of our current therapies for this condition.

Armand Butera


CDC Influenza Surveillance Weekly Report

Clinical and public health laboratories reported increased influenza virus detections over the past few weeks, but US cases remains comparatively low to previous flu seasons.

Tiana Patriarca, PharmD candidate


Linezolid Coadministration With Medications for Opioid Use Disorder: A Serotonin Toxicity Tightrope?

This study characterized the incidence of serotonin syndrome and identified contributing risk factors with combined medications for opioid use disorder (MOUD) and linezolid use.

© 2024 MJH Life Sciences

All rights reserved.